---
schema_version: "secwatch.filing_event.v1"
accession: "0001850902-26-000007"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:54:12.418267+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teknova Q1 revenue $11.1M (+13% YoY); reaffirms FY 2026 guidance $42-44M

## Summary
- Total revenue $11.1M, up 13% YoY; Clinical Solutions revenue surged 85% to $2.1M.
- Net loss $4.6M (diluted EPS -$0.08) vs $4.6M; Adjusted EBITDA improved to -$2.0M from -$2.5M.
- Gross margin expanded to 34.2% from 30.7%; Free Cash Outflow improved to $3.6M from $4.3M.
- Reaffirmed FY 2026 revenue guidance $42-44M and Free Cash Outflow under $10M.
- Cash and short-term investments $17.8M; total borrowings $13.2M at quarter end.

## SEC filing metadata
- accession: 0001850902-26-000007
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01, 5.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000185090226000007/0001850902-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000185090226000007/tkno-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001850902-26-000007
- JSON: https://secwatch.observer/filing/0001850902-26-000007.json
- Plain text: https://secwatch.observer/filing/0001850902-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.